Western blot analysis and TUNEL assays showed that axitinib treatment induced a higher level of tumor cell apoptosis in control tumors but not in those with high RNF25 expression (Figure S2H-J), indicating that elevated RNF25 levels promote axitinib resistance through anti-apoptotic mechanisms. The gene discussed is RNF25; the disease is neoplasm.